U.S. Nootropics Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Form (Powder, Drinks, Gummies), By Application, By Distribution Channel, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within 3 Business days
U.S. Nootropics Market Growth & Trends
The U.S. nootropics market size is estimated t%li%reach USD 4.68 billion in 2030, growing at a CAGR of 9.0% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.
Natural products held a major share in 2024. This is due t%li%consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of 'natural' with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies.
The drinks segment held the largest share in 2024.This can be attributed t%li%their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate int%li%daily routines, offering an easily consumable format compared t%li%capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format als%li%allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal t%li%a wider consumer base.
Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers t%li%competitive academic pursuits. Individuals are actively seeking solutions t%li%improve focus, memory, attention span, and learning capabilities t%li%gain a competitive edge and enhance productivity.
Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others t%li%gain more share of the market.
U.S. Nootropics Market Report Highlights
U.S. Nootropics Market Growth & Trends
The U.S. nootropics market size is estimated t%li%reach USD 4.68 billion in 2030, growing at a CAGR of 9.0% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. This robust expansion is primarily fueled by the increasing consumer awareness and acceptance of cognitive enhancement products. Heightened societal focus on mental performance in demanding professional and academic environments, coupled with a growing aging population concerned about cognitive decline, significantly boosts demand. Furthermore, the expanding application of nootropics beyond just cognitive enhancement, encompassing areas like mood support and stress reduction, broadens their market appeal and attracts a more diverse consumer base.
Natural products held a major share in 2024. This is due t%li%consumer preferences for health and wellness solutions perceived as gentle and safe. This preference is strongly influenced by the association of 'natural' with fewer synthetic chemicals and potentially milder side effects. The effective marketing and branding of natural nootropics, capitalizing on the broader 'clean label' and plant-based trends, further propelled their market dominance by resonating strongly with health-conscious consumers seeking cognitive enhancement solutions aligned with natural and holistic wellness philosophies.
The drinks segment held the largest share in 2024.This can be attributed t%li%their inherent convenience and accessibility for consumers. Ready-to-drink nootropic beverages seamlessly integrate int%li%daily routines, offering an easily consumable format compared t%li%capsules or powders. Furthermore, drinks often provide a perception of faster absorption and quicker onset of effects, aligning with the immediate cognitive enhancement sought by many nootropic users. The beverage format als%li%allows for greater flexibility in flavor profiles and taste masking, enhancing palatability and broadening appeal t%li%a wider consumer base.
Cognitive enhance held the largest share in the U.S. nootropics industry in 2024. The growth addresses the core and most widely recognized application of these substances. The fundamental driver is the increasing societal emphasis on optimal mental performance in various aspects of life, from demanding professional careers t%li%competitive academic pursuits. Individuals are actively seeking solutions t%li%improve focus, memory, attention span, and learning capabilities t%li%gain a competitive edge and enhance productivity.
Major market players include Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC); Unilever Onnit Labs, Inc.; Amway; GNC Holdings, LLC; NeuroGum, Inc.; Qualia Life Sciences, LLC; NOW Foods.; Performance Lab USA Corp.; Natural Stacks; BrainMD Health; and Nootropics Depot. Various steps are adopted by these companies, including new product launches, partnerships, mergers & acquisitions, global expansion, and others t%li%gain more share of the market.
U.S. Nootropics Market Report Highlights
- Based on product, the synthetic segment is estimated t%li%grow at a substantial CAGR over the forecast period. The capacity for targeted cognitive enhancement and precise formulations have stimulated the growth. Ongoing research enables the development of novel synthetic compounds with specific mechanisms of action and enhanced potency compared t%li%natural extracts. Synthetic production allows for greater control over purity and consistency, potentially leading t%li%more predictable and reliable effects, appealing t%li%users seeking optimized and tailored cognitive benefits.
- Based on form, the gummies segment is anticipated t%li%grow at a significant CAGR over the forecast period, driven by the appealing and convenient format of gummies. Gummies offer a palatable and enjoyable consumption experience, masking the potential bitterness of ingredients and resembling popular confectionery.
- Based on application, the sleep optimization segment is anticipated t%li%grow at a faster CAGR over the forecast period. The increasing recognition of sleep's crucial role in cognitive function and overall well-being and rising rates of sleep disorders and stress-induced sleep issues are driving demand for natural sleep aids.
- Based on distribution channel, the online segment is anticipated t%li%grow at a faster CAGR over the forecast period due t%li%enhanced accessibility and convenience. They offer a wider selection of nootropics compared t%li%brick-and-mortar stores, often at competitive prices due t%li%reduced overhead.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Product Outlook
2.3. Form Outlook
2.4. Application Outlook
2.5. Distribution Channel Outlook
CHAPTER 3. U.S. NOOTROPICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Manufacturing & Technology Outlook
3.2.3. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. U.S. NOOTROPICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. U.S. Nootropics Market, By Product: Key Takeaways
4.2. Product Movement Analysis & Market Share, 2024 & 2030
4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
4.3.1. Natural
4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.3.2. Synthetic
4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. NOOTROPICS MARKET: FORM ESTIMATES & TREND ANALYSIS
5.1. U.S. Nootropics Market, By Form: Key Takeaways
5.2. Form Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
5.3.1. Capsules/Tablets
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Powder
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Drinks
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Gummies
5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.5. Others (Liquid, patches, and novel delivery methods)
5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. NOOTROPICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. U.S. Nootropics Market, By Application: Key Takeaways
6.2. Application Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
6.3.1. Cognitive Enhance
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Mood & Stress Management
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Sleep Optimization
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Energy & Physical Performance
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. NOOTROPICS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
7.3.1. Offline
7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2. Online
7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE ANALYSIS
8.1. Recent developments & impact analysis, by key market participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (%)
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. Company Profiles
8.9.1. Qualia Life Sciences, LLC
8.9.1.1. Company Overview
8.9.1.2. Financial Performance
8.9.1.3. Product Portfolios
8.9.1.4. Strategic Initiatives
8.9.2. Unilever (Onnit Labs, Inc.)
8.9.2.1. Company Overview
8.9.2.2. Financial Performance
8.9.2.3. Product Portfolios
8.9.2.4. Strategic Initiatives
8.9.3. GNC Holdings, LLC
8.9.3.1. Company Overview
8.9.3.2. Financial Performance
8.9.3.3. Product Portfolios
8.9.3.4. Strategic Initiatives
8.9.4. Performance Lab USA Corp.
8.9.4.1. Company Overview
8.9.4.2. Financial Performance
8.9.4.3. Product Portfolios
8.9.4.4. Strategic Initiatives
8.9.5. NeuroGum, Inc.
8.9.5.1. Company Overview
8.9.5.2. Financial Performance
8.9.5.3. Product Portfolios
8.9.5.4. Strategic Initiatives
8.9.6. Natural Stacks
8.9.6.1. Company Overview
8.9.6.2. Financial Performance
8.9.6.3. Product Portfolios
8.9.6.4. Strategic Initiatives
8.9.7. Nootropics Depot
8.9.7.1. Company Overview
8.9.7.2. Financial Performance
8.9.7.3. Product Portfolios
8.9.7.4. Strategic Initiatives
8.9.8. BrainMD Health
8.9.8.1. Company Overview
8.9.8.2. Financial Performance
8.9.8.3. Product Portfolios
8.9.8.4. Strategic Initiatives
8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
8.9.9.1. Company Overview
8.9.9.2. Financial Performance
8.9.9.3. Product Portfolios
8.9.9.4. Strategic Initiatives
8.9.10. NOW Foods.
8.9.10.1. Company Overview
8.9.10.2. Financial Performance
8.9.10.3. Product Portfolios
8.9.10.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Product Outlook
2.3. Form Outlook
2.4. Application Outlook
2.5. Distribution Channel Outlook
CHAPTER 3. U.S. NOOTROPICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Outlook
3.2.2. Manufacturing & Technology Outlook
3.2.3. Profit Margin Analysis
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.3.3. Market Opportunities
3.3.4. Market Challenges
3.4. Industry Analysis - Porter’s Five Forces Analysis
3.5. Market Entry Strategies
CHAPTER 4. U.S. NOOTROPICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. U.S. Nootropics Market, By Product: Key Takeaways
4.2. Product Movement Analysis & Market Share, 2024 & 2030
4.3. Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
4.3.1. Natural
4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
4.3.2. Synthetic
4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. NOOTROPICS MARKET: FORM ESTIMATES & TREND ANALYSIS
5.1. U.S. Nootropics Market, By Form: Key Takeaways
5.2. Form Movement Analysis & Market Share, 2024 & 2030
5.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
5.3.1. Capsules/Tablets
5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.2. Powder
5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.3. Drinks
5.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.4. Gummies
5.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
5.3.5. Others (Liquid, patches, and novel delivery methods)
5.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. NOOTROPICS MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
6.1. U.S. Nootropics Market, By Application: Key Takeaways
6.2. Application Movement Analysis & Market Share, 2024 & 2030
6.3. Market Estimates & Forecasts, by Application, 2018 - 2030 (USD Million)
6.3.1. Cognitive Enhance
6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.2. Mood & Stress Management
6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Sleep Optimization
6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Energy & Physical Performance
6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
6.3.5. Others (Microcirculation, Anti-Aging & Longevity, Social Anxiety & Confidence Enhancement, Creativity boosting)
6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. NOOTROPICS MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
7.1. U.S. Nootropics Market, By Distribution Channel: Key Takeaways
7.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
7.3. Market Estimates & Forecasts, by Form, 2018 - 2030 (USD Million)
7.3.1. Offline
7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
7.3.2. Online
7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE ANALYSIS
8.1. Recent developments & impact analysis, by key market participants
8.2. Company Categorization
8.3. Participant’s Overview
8.4. Financial Performance
8.5. Product Benchmarking
8.6. Company Market Share Analysis, 2024 (%)
8.7. Company Heat Map Analysis
8.8. Strategy Mapping
8.9. Company Profiles
8.9.1. Qualia Life Sciences, LLC
8.9.1.1. Company Overview
8.9.1.2. Financial Performance
8.9.1.3. Product Portfolios
8.9.1.4. Strategic Initiatives
8.9.2. Unilever (Onnit Labs, Inc.)
8.9.2.1. Company Overview
8.9.2.2. Financial Performance
8.9.2.3. Product Portfolios
8.9.2.4. Strategic Initiatives
8.9.3. GNC Holdings, LLC
8.9.3.1. Company Overview
8.9.3.2. Financial Performance
8.9.3.3. Product Portfolios
8.9.3.4. Strategic Initiatives
8.9.4. Performance Lab USA Corp.
8.9.4.1. Company Overview
8.9.4.2. Financial Performance
8.9.4.3. Product Portfolios
8.9.4.4. Strategic Initiatives
8.9.5. NeuroGum, Inc.
8.9.5.1. Company Overview
8.9.5.2. Financial Performance
8.9.5.3. Product Portfolios
8.9.5.4. Strategic Initiatives
8.9.6. Natural Stacks
8.9.6.1. Company Overview
8.9.6.2. Financial Performance
8.9.6.3. Product Portfolios
8.9.6.4. Strategic Initiatives
8.9.7. Nootropics Depot
8.9.7.1. Company Overview
8.9.7.2. Financial Performance
8.9.7.3. Product Portfolios
8.9.7.4. Strategic Initiatives
8.9.8. BrainMD Health
8.9.8.1. Company Overview
8.9.8.2. Financial Performance
8.9.8.3. Product Portfolios
8.9.8.4. Strategic Initiatives
8.9.9. Reckitt Benckiser Group PLC (Schiff RB Health (US) LLC)
8.9.9.1. Company Overview
8.9.9.2. Financial Performance
8.9.9.3. Product Portfolios
8.9.9.4. Strategic Initiatives
8.9.10. NOW Foods.
8.9.10.1. Company Overview
8.9.10.2. Financial Performance
8.9.10.3. Product Portfolios
8.9.10.4. Strategic Initiatives
